Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Morgan Stanley Maintains Equal-Weight on NuVasive, Lowers Price Target to $43

Author: Benzinga Newsdesk | May 11, 2023 08:27am

Morgan Stanley analyst Jonathan Demchick maintains NuVasive (NASDAQ:NUVA) with a Equal-Weight and lowers the price target from $44.5 to $43.

Posted In: NUVA